desethylamiodarone has been researched along with Liver Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hanniman, EA; McCarthy, TC; Pollak, PT; Sinal, CJ | 1 |
Bakker, O; Hudig, F; Meijssen, S; Wiersinga, WM | 1 |
2 other study(ies) available for desethylamiodarone and Liver Neoplasms
Article | Year |
---|---|
Disruption of hepatic lipid homeostasis in mice after amiodarone treatment is associated with peroxisome proliferator-activated receptor-alpha target gene activation.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Blood Glucose; Blotting, Northern; Body Weight; Cell Line, Tumor; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Gene Expression Regulation; Genes, Reporter; Hepatocytes; Hepatomegaly; Homeostasis; Lipid Metabolism; Liver; Liver Neoplasms; Mice; Mice, Inbred C57BL; Mice, Knockout; PPAR alpha; Transcriptional Activation | 2004 |
Effects of triiodothyronine and amiodarone on the promoter of the human LDL receptor gene.
Topics: Amiodarone; Anti-Arrhythmia Agents; Carcinoma, Hepatocellular; Gene Expression; Humans; Liver Neoplasms; Promoter Regions, Genetic; Receptors, LDL; Receptors, Thyroid Hormone; Transfection; Triiodothyronine; Tumor Cells, Cultured | 1998 |